Sirona Biochem Corp Ord

0.1583+0.0139+9.63%Vol 214.10K1Y Perf -11.47%
Dec 3rd, 2021 15:41
BID0.0000 ASK0.0000
Open0.1563 Previous Close0.1444
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     39.48
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
10.43 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha0.02 Standard Deviation0.21
Beta-0.26 

Today's Price Range

0.15630.1650

52W Range

0.12470.4470

5 Year PE Ratio Range

-7.7000-4.4000

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.19%
1 Month
0.32%
3 Months
0.51%
6 Months
-29.05%
1 Year
-11.47%
3 Years
124.54%
5 Years
22.62%
10 Years
0.00%

TickerPriceChg.Chg.%
SRBCF0.15830.01399.63
AAPL161.84-1.9200-1.17
GOOG2 850.41-25.1200-0.87
MSFT323.01-6.4800-1.97
XOM60.89-0.3900-0.64
WFC47.75-1.1600-2.37
JNJ159.382.29001.46
FB306.84-3.5500-1.14
GE92.77-2.4600-2.58
JPM158.29-2.9200-1.81
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.10
0.95
26.20
-263.30
Leverage Ratio -2.90
ProfitabilityValueIndustryS&P 500US Markets
-
-701.70
-696.70
-18 610.10
-
RevenueValueIndustryS&P 500US Markets
186.95K
0.00
-45.70
15.99
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume214.10K
Shares Outstanding0
Shares Float229.89M
Trades Count12
Dollar Volume35.14K
Avg. Volume45.00K
Avg. Weekly Volume113.62K
Avg. Monthly Volume68.28K
Avg. Quarterly Volume74.73K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Sirona Biochem Corp Ord

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of safer, more effective cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules.

CEO: Howard Verrico

Telephone:

Address: 605 - 889 West Pender Street, Vancouver V6C 3B2, BC, CAN

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

56%44%

Bearish Bullish

56%44%

News